Investor Group Appointed Lead Plaintiff In Lipocine Securities Class Action
TRENTON, N.J. — A federal judge in New Jersey on Dec. 2 appointed an investor group as lead plaintiff in a securities class action lawsuit against a pharmaceutical company and certain...To view the full article, register now.
Already a subscriber? Click here to view full article